Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi AventisfiledCriticalSanofi Aventis
Priority to UY30516ApriorityCriticalpatent/UY30516A1/en
Publication of UY30516A1publicationCriticalpatent/UY30516A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
La invencion se refiere a compuestos de la formula I que tienen actividad antitrombotica, que en particular inhiben el receptor activado por proteasas tipo 1 (PAR1), procedimientos para su preparacion y su uso como medicamentos.The invention relates to compounds of the formula I that have antithrombotic activity, which in particular inhibit the type 1 protease activated receptor (PAR1), methods for its preparation and its use as medicaments.
UY30516A2007-07-312007-07-31
IMINOIMIDAZOPIRIDINE DERIVATIVES THAT HAVE ANTITROMBOTIC ACTIVITY
UY30516A1
(en)